HAEMONETICS CORP
HAEMONETICS CORP
Aktie · US4050241003 · HAE · 881782 (XNYS)
Übersicht Finanzkennzahlen
72,55 USD
-1,23 % -0,90 USD
NYSE (XNYS) · Aktuelle Kurse und Charts bei MoneyPeak
18.07.2025 20:00

Aktuelle Kurse von HAEMONETICS CORP

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNYS: NYSE
NYSE
HAE
USD
18.07.2025 20:00
72,55 USD
73,45 USD
-1,23 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -3,93 % 3,55 % 26,90 % -1,28 % -16,21 % -21,14 %

Firmenprofil zu HAEMONETICS CORP Aktie

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Unternehmensdaten

Name HAEMONETICS CORP
Firma Haemonetics Corporation
Symbol HAE
Website https://www.haemonetics.com
Heimatbörse XNYS NYSE
WKN 881782
ISIN US4050241003
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Instruments & Supplies
CEO Mr. Christopher A. Simon
Marktkapitalisierung 3 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 3,7 T
Adresse 125 Summer Street, 02110 Boston
IPO Datum 1991-05-10

Aktien-Splits

Datum Split
03.12.2012 2:1
11.01.1993 2:1

Ticker Symbole

Name Symbol
Frankfurt HAZ.F
NYSE HAE

Weitere Aktien

Investoren die HAEMONETICS CORP die halten, haben auch folgende Aktien im Depot:
ALLIANZ FDS JAPAN A (EUR)
ALLIANZ FDS JAPAN A (EUR) Fonds
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
BANCFIRSTCORP - 7.2% CUMULATIVE TRUST PREFERRED SECURITIES
BANCFIRSTCORP - 7.2% CUMULATIVE TRUST PREFERRED SECURITIES Fonds
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
DZ BANK      IS.A2601
DZ BANK IS.A2601 Anleihe
EUROPEAN BANK FOR RECONSTRUCTION & DEVELOPMENT 2.746% IDX NTS 17/07/24
EUROPEAN BANK FOR RECONSTRUCTION & DEVELOPMENT 2.746% IDX NTS 17/07/24 Anleihe
INTEL CORP
INTEL CORP Aktie
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NEO
NEO Crypto
NXP SEMICONDUCTORS NV
NXP SEMICONDUCTORS NV Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025